These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23789)

  • 1. [Effect of a new beta-adrenoceptor blocking agent, carteolol (OPC-1085). Improvement of the coronary collateral circulation in dogs with chronic coronary artery occlusion (author's transl)].
    Ishihara T; Watanabe K; Takenaka F
    Arzneimittelforschung; 1977; 27(11):2055-9. PubMed ID: 23789
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transmural coronary blood flow redistribution in the non-ischemic and ischemic canine myocardium with S 2395, a beta-adrenoceptor blocking agent (author's transl)].
    Berdeaux PA; Giudicelli JF
    Arch Farmacol Toxicol; 1980 Dec; 6(3):209-24. PubMed ID: 6118102
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the action of talinolol (Cordanum, 02-115) on the coronary blood circulation].
    Modersohn D; Femmer K
    Pharmazie; 1975 Oct; 30(10):652-5. PubMed ID: 689
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of Kö 1366 and propranolol on hemodynamics and regional myocardial blood flow in the selective coronary hypotensive dogs (author's transl)].
    Tomoike H
    Fukuoka Igaku Zasshi; 1975 Apr; 66(4):301-19. PubMed ID: 237808
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of a new beta blockader (SD/1601) on positive levelling of the ST epicardial tracing during coronary occlusion in the narcotized dog].
    Merlo L; Brusoni B; Minoia G; Marchetti G
    Boll Soc Ital Biol Sper; 1977 Mar; 53(6):440-4. PubMed ID: 20906
    [No Abstract]   [Full Text] [Related]  

  • 6. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
    Reyes G; Ramírez T; Hong E
    Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323
    [No Abstract]   [Full Text] [Related]  

  • 7. Nipradilol, a beta-adrenoceptor antagonist having a vasodilatory action, attenuates myocardial acidosis induced by coronary artery occlusion in dogs.
    Hino T; Hayase N; Chiba K; Ichihara K; Abiko Y
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):373-8. PubMed ID: 2568518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
    Sugawara K; Takami N; Ozaki M
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

  • 10. Atenolol, regional myocardial blood flow and S-T segment in canine ischaemic myocardium [proceedingins].
    Berdeaux A; Boissier JR; Giudicelli JF
    Br J Pharmacol; 1976 Nov; 58(3):411P. PubMed ID: 11019
    [No Abstract]   [Full Text] [Related]  

  • 11. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
    Haustein KO; Fiehring H; Oltmanns G; Femmer K
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodynamic studies at rest and under stress in patients with coronary heart disease after administration of carteolol].
    Saborowski F; Dundalek E; Griebenow R; Sy M
    Arzneimittelforschung; 1983; 33(2a):310-2. PubMed ID: 6682322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and beta-adrenoreceptor blocking effects of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB-46) on myocardial hemodynamics.
    Laddu AR; Somani P
    Arch Int Pharmacodyn Ther; 1972 Mar; 196(1):5-15. PubMed ID: 4400602
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary and myocardial effects of dopamine in the conscious dog: parasympatholytic augmentation of pressor and inotropic actions.
    Vatner SF; Millard RW; Higgins CB
    J Pharmacol Exp Ther; 1973 Nov; 187(2):280-95. PubMed ID: 4147854
    [No Abstract]   [Full Text] [Related]  

  • 15. A further study on antihypertensive action of beta-adrenoceptor blocking agents in conscious, renal hypertensive dogs.
    Himori N; Ishimori T; Taira N
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):115-27. PubMed ID: 44454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular responses to phenylephrine and sodium nitroprusside during acute coronary occlusion in dogs.
    Hussain ME; Fahim M
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):252-8. PubMed ID: 7883288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S; Femmer K
    Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
    Reale A; Motolese M; Imhof P
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):288-93. PubMed ID: 4394124
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta adrenergic blockade on intramyocardial distribution of coronary blood flow.
    Gross GJ; Winbury MM
    J Pharmacol Exp Ther; 1973 Dec; 187(3):451-64. PubMed ID: 4149128
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-blocking and hemodynamic effects of ASL-8052.
    Gorczynski RJ; Murthy VS; Hwang TF
    J Cardiovasc Pharmacol; 1984; 6(6):1548-59. PubMed ID: 6084788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.